CoChat

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

NFĸB signaling drives myocardial injury via CCR2+ macrophages in a preclinical model of arrhythmogenic cardiomyopathy

Open access

Abstract

Nuclear factor κ-B (NFκB) is activated in iPSC-cardiac myocytes from patients with arrhythmogenic cardiomyopathy (ACM) under basal conditions, and inhibition of NFκB signaling prevents disease in Dsg2 mut/mut mice, a robust mouse model of ACM. Here, we used genetic approaches and single-cell RNA-Seq to define the contributions of immune signaling in cardiac myocytes and macrophages in the natural progression of ACM using Dsg2 mut/mut mice. We found that NFκB signaling in cardiac myocytes drives myocardial injury, contractile dysfunction, and arrhythmias in Dsg2 mut/mut mice. NFκB signaling in cardiac myocytes mobilizes macrophages expressing C-C motif chemokine receptor-2 (CCR2 + cells) to affected areas within the heart, where they mediate myocardial injury and arrhythmias. Contractile dysfunction in Dsg2 mut/mut mice is caused both by loss of heart muscle and negative inotropic effects of inflammation in viable muscle. Single nucleus RNA-Seq and cellular indexing of transcriptomes and epitomes (CITE-Seq) studies revealed marked proinflammatory changes in gene expression and the cellular landscape in hearts of Dsg2 mut/mut mice involving cardiac myocytes, fibroblasts, and CCR2 + macrophages. Changes in gene expression in cardiac myocytes and fibroblasts in Dsg2 mut/mut mice were dependent on CCR2 + macrophage recruitment to the heart. These results highlight complex mechanisms of immune injury and regulatory crosstalk between cardiac myocytes, inflammatory cells, and fibroblasts in the pathogenesis of ACM.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci172014

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 NFκB signaling in cardiac myocytes mobilizes CCR2+ macrophages to the heart. (A) Quantification of Evans Blue+ cardiac myocytes (per ×20) field in 16-week-old WT (n = 7), Dsg2mut/mut (n = 10) and Dsg2mut/mut × IκBαΔN (n = 5) mice. (B) Representative immunostained myocardium showing CD68+ (violet) cells located in close proximity to Evans Blue+ cardiac myocytes (red). Scale bars: 40 μm. (C) Representative RNA in situ hybridization images (RNAscope) showing CCR2+ (green) cells in close proximity to Evans Blue+ cardiac myocytes (red). Scale bars: 40 μm. (D) Representative RNA in situ hybridization images (RNAscope) showing Ccr2+ (red) cells in 16-week-old mice. Scale bars: 40 μm. (E) Quantification of Ccr2+ cells in mice. WT, n = 10 samples; Dsg2mut/mut, n = 9 samples; Dsg2mut/mut × IκBαΔN, n = 10 samples. Data presented as mean ± SEM; P values inset; determined via 1-way ANOVA with Tukey’s post hoc analysis.
Figure 1 NFκB signaling in cardiac myocytes mobilizes CCR2+ macrophages to the heart. (A) Quantification of Evans Blue+ cardiac myocytes (per ×20) field in 16-week-old WT (n = 7), Dsg2mut/mut (n = 10) and Dsg2mut/mut × IκBαΔN (n = 5) mice. (B) Representative immunostained myocardium showing CD68+ (violet) cells located in close proximity to Evans Blue+ cardiac myocytes (red). Scale bars: 40 μm. (C) Representative RNA in situ hybridization images (RNAscope) showing CCR2+ (green) cells in close proximity to Evans Blue+ cardiac myocytes (red). Scale bars: 40 μm. (D) Representative RNA in situ hybridization images (RNAscope) showing Ccr2+ (red) cells in 16-week-old mice. Scale bars: 40 μm. (E) Quantification of Ccr2+ cells in mice. WT, n = 10 samples; Dsg2mut/mut, n = 9 samples; Dsg2mut/mut × IκBαΔN, n = 10 samples. Data presented as mean ± SEM; P values inset; determined via 1-way ANOVA with Tukey’s post hoc analysis.CC BY · PubMed Central
Figure 2 Blocking activation of NFκB signaling in cardiac myocytes mitigates myocardial injury and arrhythmias and preserves cardiac function in Dsg2mut/mut mice. (A) Representative trichrome-stained hearts from mice at 16 weeks of age (16 wk). Scale bars: 1 mm. (B) Percent (%) fibrosis at 16 wk; WT (n = 18), Dsg2mut/mut (n = 15), Dsg2mut/mut × IκBαΔN (n = 17), and Dsg2mut/mut × Ccr2–/– mice (n = 22). (C) Representative echocardiographs from 16 wk mice; yellow scale bar: 6 mm. (D) Percent left ventricular ejection fraction (%LVEF). Note, preserved cardiac function in Dsg2mut/mut × IκBαΔN mice. WT (n = 49), Dsg2mut/mut (n = 30), Dsg2mut/mut × IκBαΔN (n = 15), and Dsg2mut/mut × Ccr2–/– mice (n = 15). *P < 0.05 any cohort versus WT; †P < 0.05 any cohort versus Dsg2mut/mut; ‡P < 0.05 Dsg2mut/mut × Ccr2–/– versus Dsg2mut/mut × IκBαΔN mice; using 1-way ANOVA with Tukey’s posthoc analysis. (E) Representative ECGs from 16 wk mice. Premature ventricular contractions (PVCs) are noted by red arrows. (F and G) QRS duration (QRSd) and percent PVCs (% PVCs), respectively, obtained from signal averaged ECGs. QRSd: WT (n = 49), Dsg2mut/mut (n = 27), Dsg2mut/mut × IκBαΔN (n = 15), and Dsg2mut/mut × Ccr2–/– mice (n = 14). %PVCs: WT (n = 49), Dsg2mut/mut (n = 30), Dsg2mut/mut × IκBαΔN (n = 15), and Dsg2mut/mut × Ccr2–/– mice (n = 15). Data presented as mean ± SEM; *P < 0.05 any cohort versus WT; †P < 0.05 any cohort versus Dsg2mut/mut; ‡P < 0.05 Dsg2mut/mut × Ccr2–/– versus. Dsg2mut/mut × IκBαΔN mice; using 1-way ANOVA with Tukey’s post hoc analysis.
Figure 2 Blocking activation of NFκB signaling in cardiac myocytes mitigates myocardial injury and arrhythmias and preserves cardiac function in Dsg2mut/mut mice. (A) Representative trichrome-stained hearts from mice at 16 weeks of age (16 wk). Scale bars: 1 mm. (B) Percent (%) fibrosis at 16 wk; WT (n = 18), Dsg2mut/mut (n = 15), Dsg2mut/mut × IκBαΔN (n = 17), and Dsg2mut/mut × Ccr2–/– mice (n = 22). (C) Representative echocardiographs from 16 wk mice; yellow scale bar: 6 mm. (D) Percent left ventricular ejection fraction (%LVEF). Note, preserved cardiac function in Dsg2mut/mut × IκBαΔN mice. WT (n = 49), Dsg2mut/mut (n = 30), Dsg2mut/mut × IκBαΔN (n = 15), and Dsg2mut/mut × Ccr2–/– mice (n = 15). *P < 0.05 any cohort versus WT; †P < 0.05 any cohort versus Dsg2mut/mut; ‡P < 0.05 Dsg2mut/mut × Ccr2–/– versus Dsg2mut/mut × IκBαΔN mice; using 1-way ANOVA with Tukey’s posthoc analysis. (E) Representative ECGs from 16 wk mice. Premature ventricular contractions (PVCs) are noted by red arrows. (F and G) QRS duration (QRSd) and percent PVCs (% PVCs), respectively, obtained from signal averaged ECGs. QRSd: WT (n = 49), Dsg2mut/mut (n = 27), Dsg2mut/mut × IκBαΔN (n = 15), and Dsg2mut/mut × Ccr2–/– mice (n = 14). %PVCs: WT (n = 49), Dsg2mut/mut (n = 30), Dsg2mut/mut × IκBαΔN (n = 15), and Dsg2mut/mut × Ccr2–/– mice (n = 15). Data presented as mean ± SEM; *P < 0.05 any cohort versus WT; †P < 0.05 any cohort versus Dsg2mut/mut; ‡P < 0.05 Dsg2mut/mut × Ccr2–/– versus. Dsg2mut/mut × IκBαΔN mice; using 1-way ANOVA with Tukey’s post hoc analysis.CC BY · PubMed Central
Figure 3 NFκB signaling in cardiac myocytes mobilizes inflammatory cells to the heart in Dsg2mut/mut mice. (A) Representative immunostained myocardial sections from 16-week-old (16 wk) mice showing CD68+ (violet) and Lyve1+ (white) cells. DAPI (blue); Scale bars: 40 μm. (B and C) Quantification of CD68+ cells and Lyve1+ cells as a percentage of CD68+ cells in mice. Data presented as mean ± SEM; n = 10 for WT, Dsg2mut/mut × IκBαΔN and Dsg2mut/mut × Ccr2–/– mice and n = 9 for Dsg2mut/mut mice. *P < 0.05 any cohort versus WT; †P < 0.05 any cohort versus Dsg2mut/mut; using 1-way ANOVA with Tukey’s post hoc analysis.
Figure 3 NFκB signaling in cardiac myocytes mobilizes inflammatory cells to the heart in Dsg2mut/mut mice. (A) Representative immunostained myocardial sections from 16-week-old (16 wk) mice showing CD68+ (violet) and Lyve1+ (white) cells. DAPI (blue); Scale bars: 40 μm. (B and C) Quantification of CD68+ cells and Lyve1+ cells as a percentage of CD68+ cells in mice. Data presented as mean ± SEM; n = 10 for WT, Dsg2mut/mut × IκBαΔN and Dsg2mut/mut × Ccr2–/– mice and n = 9 for Dsg2mut/mut mice. *P < 0.05 any cohort versus WT; †P < 0.05 any cohort versus Dsg2mut/mut; using 1-way ANOVA with Tukey’s post hoc analysis.CC BY · PubMed Central
Figure 4 NFκB signaling in cardiac myocytes and actions of CCR2+ cells increase myocardial cytokines levels in Dsg2mut/mut mice. (A) Representative immunoblots from myocardial cytokine arrays in WT (n = 6), Dsg2mut/mut (n = 6), Dsg2mut/mut × Ccr2–/– (n = 6), and Dsg2mut/mut × IκBαΔN (n = 5) mice. Ref. Band, Reference Band. (B–G) Bar graphs comparing levels of selected cytokines normalized to WT hearts. Data presented as mean ± SEM; *P < 0.05 any cohort versus WT; †P < 0.05 any cohort versus Dsg2mut/mut; ‡P < 0.05 any cohort versus Dsg2mut/mut × IκBαΔN using 1-way ANOVA with Tukey’s posthoc analysis.
Figure 4 NFκB signaling in cardiac myocytes and actions of CCR2+ cells increase myocardial cytokines levels in Dsg2mut/mut mice. (A) Representative immunoblots from myocardial cytokine arrays in WT (n = 6), Dsg2mut/mut (n = 6), Dsg2mut/mut × Ccr2–/– (n = 6), and Dsg2mut/mut × IκBαΔN (n = 5) mice. Ref. Band, Reference Band. (B–G) Bar graphs comparing levels of selected cytokines normalized to WT hearts. Data presented as mean ± SEM; *P < 0.05 any cohort versus WT; †P < 0.05 any cohort versus Dsg2mut/mut; ‡P < 0.05 any cohort versus Dsg2mut/mut × IκBαΔN using 1-way ANOVA with Tukey’s posthoc analysis.CC BY · PubMed Central
Figure 5 CITE-Seq reveals expansion of CCR2+ inflammatory macrophages in hearts of Dsg2mut/mut mice. (A) Schematic depicting design of CITE-Seq experiments. Whole hearts from n = 3 mice per condition were homogenized and enzymatically digested. (B) Uniform Manifold Approximation and Projection (UMAP) of 8,775 cells after quality control (QC) and data filtering using standard Seurat pipeline. (C) UMAP reclustering of macrophage/monocyte population. (D) Composition graph showing proportion of different populations within the macrophage/monocyte cluster. (E) Gaussian kernel density estimation of cells within the macrophage/monocyte cluster across the indicated genotypes. (F) Heatmap of top 25 differentially expressed genes in the macrophage/monocyte cluster between WT and Dsg2mut/mut mice with sideby-side comparison of the expression of those same genes from Dsg2mut/mut × Ccr2–/– mice. Example genes are annotated. (G) Z-score feature plot, overlaying an inflammatory gene signature derived from the heatmap in F (genes listed to the side) and displayed on the macrophage/monocyte UMAP projection split by genotype. (H) Graph of Z-score values for inflammatory gene signature derived from heatmap in F compared across genotypes. Data presented as a box-and-whisker plot. The 5 number summary (minimum, 25% IQR, median, 75% IQR, and maximum) as well as total number of values for each group is provided as follows; WT: –0.7688, –0.4471, –0.3135, –0.005451, 1.337, n = 100; Dsg2mut/mut: –0.6884, –0.1186, 0.1394, 0.7270, 1.923, n = 124; Dsg2mut/mut × Ccr2–/–: –0.6941, –0.3559, –0.2186, –0.005207, 1,752, n = 145. P values inset and determined via 1-way ANOVA. (I) Top GO Biological pathways for the top 25 differentially upregulated genes in WT versus. Dsg2mut/mut mice (red) and WT versus Dsg2mut/mut × Ccr2–/– mice (blue) (derived from F).
Figure 5 CITE-Seq reveals expansion of CCR2+ inflammatory macrophages in hearts of Dsg2mut/mut mice. (A) Schematic depicting design of CITE-Seq experiments. Whole hearts from n = 3 mice per condition were homogenized and enzymatically digested. (B) Uniform Manifold Approximation and Projection (UMAP) of 8,775 cells after quality control (QC) and data filtering using standard Seurat pipeline. (C) UMAP reclustering of macrophage/monocyte population. (D) Composition graph showing proportion of different populations within the macrophage/monocyte cluster. (E) Gaussian kernel density estimation of cells within the macrophage/monocyte cluster across the indicated genotypes. (F) Heatmap of top 25 differentially expressed genes in the macrophage/monocyte cluster between WT and Dsg2mut/mut mice with sideby-side comparison of the expression of those same genes from Dsg2mut/mut × Ccr2–/– mice. Example genes are annotated. (G) Z-score feature plot, overlaying an inflammatory gene signature derived from the heatmap in F (genes listed to the side) and displayed on the macrophage/monocyte UMAP projection split by genotype. (H) Graph of Z-score values for inflammatory gene signature derived from heatmap in F compared across genotypes. Data presented as a box-and-whisker plot. The 5 number summary (minimum, 25% IQR, median, 75% IQR, and maximum) as well as total number of values for each group is provided as follows; WT: –0.7688, –0.4471, –0.3135, –0.005451, 1.337, n = 100; Dsg2mut/mut: –0.6884, –0.1186, 0.1394, 0.7270, 1.923, n = 124; Dsg2mut/mut × Ccr2–/–: –0.6941, –0.3559, –0.2186, –0.005207, 1,752, n = 145. P values inset and determined via 1-way ANOVA. (I) Top GO Biological pathways for the top 25 differentially upregulated genes in WT versus. Dsg2mut/mut mice (red) and WT versus Dsg2mut/mut × Ccr2–/– mice (blue) (derived from F).CC BY · PubMed Central
Figure 6 PostN+ fibroblasts are expanded in Dsg2mut/mut hearts through a CCR2+ monocyte- and macrophage-dependent mechanism. (A) UMAP re-clustering of fibroblast population. (B) Gaussian kernel density estimation of cells within the fibroblast cluster across the indicated genotypes. (C) Heatmap of top 25 differentially expressed genes in the fibroblast cluster between WT and Dsg2mut/mut mice with sideby-side comparison of the expression of those same genes from Dsg2mut/mut × Ccr2–/– mice. Example genes are annotated. (D) Z-score feature plot, overlaying a fibroblast gene signature derived from the heatmap in C (genes listed to the side) and displayed on the fibroblast UMAP projection, split by genotype. (E) Graph of Z-score values for fibroblast gene signature derived from heatmap in C compared across genotypes. Data presented as a box-and-whisker plot. The 5 number summary (minimum, 25% IQR, median, 75% IQR, and maximum) as well as total number of values for each group is provided as follows; WT: –0.7450, –0.4597, –0.2805, –0.07749, 0.9996, n = 1717; Dsg2mut/mut: –0.6437, –0.008809, 0.2165, 0.4886, 1.611, n = 1675; Dsg2mut/mut × Ccr2–/–: –0.7450, –0.2865, –0.06280, –0.2262, 1,371, n = 2625. P values inset and determined by 1-way ANOVA. (F) Top GO Biological pathways for the top 25 differentially upregulated genes in WT versus Dsg2mut/mut mice (red) and WT versus Dsg2mut/mut × Ccr2–/– mice (blue) (derived from C). (G) Representative immunostained myocardium displaying colocalization of CCR2+ macrophages (green) with Periostin+ (PostN+) fibroblasts (red) at 16 weeks of age. Scale bars: 60 μm. (H) Representative immunostained myocardium depicting PostN+ (red) areas via immunofluorescence staining from mice aged 16 weeks from indicated genotypes. Scale bars: 40 μm. (I) Quantification of PostN+ area as a percentage of total area in mice of the indicated genotypes (P values inset, determined via 1-way ANOVA); WT (n = 5); Dsg2mut/mut (n = 4); and Dsg2mut/mut × Ccr2–/– (n = 4). Data presented as mean ± SEM, n = 4 per cohort, P values inset and determined via 1-way ANOVA.
Figure 6 PostN+ fibroblasts are expanded in Dsg2mut/mut hearts through a CCR2+ monocyte- and macrophage-dependent mechanism. (A) UMAP re-clustering of fibroblast population. (B) Gaussian kernel density estimation of cells within the fibroblast cluster across the indicated genotypes. (C) Heatmap of top 25 differentially expressed genes in the fibroblast cluster between WT and Dsg2mut/mut mice with sideby-side comparison of the expression of those same genes from Dsg2mut/mut × Ccr2–/– mice. Example genes are annotated. (D) Z-score feature plot, overlaying a fibroblast gene signature derived from the heatmap in C (genes listed to the side) and displayed on the fibroblast UMAP projection, split by genotype. (E) Graph of Z-score values for fibroblast gene signature derived from heatmap in C compared across genotypes. Data presented as a box-and-whisker plot. The 5 number summary (minimum, 25% IQR, median, 75% IQR, and maximum) as well as total number of values for each group is provided as follows; WT: –0.7450, –0.4597, –0.2805, –0.07749, 0.9996, n = 1717; Dsg2mut/mut: –0.6437, –0.008809, 0.2165, 0.4886, 1.611, n = 1675; Dsg2mut/mut × Ccr2–/–: –0.7450, –0.2865, –0.06280, –0.2262, 1,371, n = 2625. P values inset and determined by 1-way ANOVA. (F) Top GO Biological pathways for the top 25 differentially upregulated genes in WT versus Dsg2mut/mut mice (red) and WT versus Dsg2mut/mut × Ccr2–/– mice (blue) (derived from C). (G) Representative immunostained myocardium displaying colocalization of CCR2+ macrophages (green) with Periostin+ (PostN+) fibroblasts (red) at 16 weeks of age. Scale bars: 60 μm. (H) Representative immunostained myocardium depicting PostN+ (red) areas via immunofluorescence staining from mice aged 16 weeks from indicated genotypes. Scale bars: 40 μm. (I) Quantification of PostN+ area as a percentage of total area in mice of the indicated genotypes (P values inset, determined via 1-way ANOVA); WT (n = 5); Dsg2mut/mut (n = 4); and Dsg2mut/mut × Ccr2–/– (n = 4). Data presented as mean ± SEM, n = 4 per cohort, P values inset and determined via 1-way ANOVA.CC BY · PubMed Central
Figure 7 snRNA-Seq reveals a role for CCR2+ monocytes and macrophages in cardiac myocyte remodeling in ACM. (A) Schematic depicting design of snRNA-Seq experiments. Frozen whole hearts (n = 3 mice per group) were mechanically homogenized. (B) UMAP of 13,176 nuclei after QC and data filtering using standard Seurat pipeline. (C) UMAP reclustering of cardiac myocyte population. (D) Composition graph showing proportion of different populations within the cardiac myocyte cluster. (E) Gaussian kernel density estimation of cells within the cardiac myocyte cluster across the indicated genotypes. (F) Heatmap of top 25 differentially expressed genes in the cardiac myocyte cluster between WT and Dsg2mut/mut mice with side-by-side comparison of the expression of those same genes from Dsg2mut/mut × Ccr2–/–. Example genes are annotated. (G) Z-score feature plot, overlaying a cardiac myocyte gene signature derived from the heatmap in F (genes listed to the side) and displayed on the cardiac myocyte UMAP projection split by genotype. (H) Graph of Z-score values for cardiac myocyte gene signature derived from heatmap in F compared across genotypes. Data presented as a box-and-whisker plot. The 5 number summary (minimum, 25% IQR, median, 75% IQR, and maximum) as well as total number of values for each group is provided as follows; WT: –0.8992, –0.3708, –0.2077, –0.04161, 0.7185, n = 564; Dsg2mut/mut: –0.5954, –0.01474, 0.2699, 0.6183, 1.742, n = 412; Dsg2mut/mut × Ccr2–/–: –0.8130, –0.2706, –0.08073, –0.1536, 1,705, n = 659. P values inset and determined via 1-way ANOVA. (I) Top GO Biological pathways for the top 25 differentially upregulated genes in WT versus Dsg2mut/mut mice (red) and WT versus Dsg2mut/mut × Ccr2–/– mice (blue) (derived from F).
Figure 7 snRNA-Seq reveals a role for CCR2+ monocytes and macrophages in cardiac myocyte remodeling in ACM. (A) Schematic depicting design of snRNA-Seq experiments. Frozen whole hearts (n = 3 mice per group) were mechanically homogenized. (B) UMAP of 13,176 nuclei after QC and data filtering using standard Seurat pipeline. (C) UMAP reclustering of cardiac myocyte population. (D) Composition graph showing proportion of different populations within the cardiac myocyte cluster. (E) Gaussian kernel density estimation of cells within the cardiac myocyte cluster across the indicated genotypes. (F) Heatmap of top 25 differentially expressed genes in the cardiac myocyte cluster between WT and Dsg2mut/mut mice with side-by-side comparison of the expression of those same genes from Dsg2mut/mut × Ccr2–/–. Example genes are annotated. (G) Z-score feature plot, overlaying a cardiac myocyte gene signature derived from the heatmap in F (genes listed to the side) and displayed on the cardiac myocyte UMAP projection split by genotype. (H) Graph of Z-score values for cardiac myocyte gene signature derived from heatmap in F compared across genotypes. Data presented as a box-and-whisker plot. The 5 number summary (minimum, 25% IQR, median, 75% IQR, and maximum) as well as total number of values for each group is provided as follows; WT: –0.8992, –0.3708, –0.2077, –0.04161, 0.7185, n = 564; Dsg2mut/mut: –0.5954, –0.01474, 0.2699, 0.6183, 1.742, n = 412; Dsg2mut/mut × Ccr2–/–: –0.8130, –0.2706, –0.08073, –0.1536, 1,705, n = 659. P values inset and determined via 1-way ANOVA. (I) Top GO Biological pathways for the top 25 differentially upregulated genes in WT versus Dsg2mut/mut mice (red) and WT versus Dsg2mut/mut × Ccr2–/– mice (blue) (derived from F).CC BY · PubMed Central
Figure 8 Contractile dysfunction is rescued in Dsg2mut/mut × Ccr2–/– mice via NFκB-inhibition. (A and B) Percent left ventricular ejection fraction (%LVEF) at 16 (16 wk) and 24 weeks (24 wk) of age in Dsg2mut/mut and Dsg2mut/mut × Ccr2–/– mice treated for 8 weeks with either vehicle (Veh) or the NFκB inhibitor, Bay11-7082 (Bay11; 5 mg/kg/day via continuous infusion at 0.11 μL/h for 8 weeks). Note, preserved cardiac function in Veh-treated Dsg2mut/mut × Ccr2–/– mice, whereas Bay11-treated Dsg2mut/mut × Ccr2–/– mice showed notable improvement in function following 8 weeks of Bay11 treatment. (C) Percent PVCs (%PVCs) at 24 wk. (D and E) Left ventricular internal diameter in diastole (LV diameter;d) and systole (LV diameter;s) at 16 wk and 24 wk in Dsg2mut/mut and Dsg2mut/mut × Ccr2–/– mice treated with either Veh or Bay11. (F) Representative trichrome-stained hearts (Scale bar: 1 mm) and (G) percent (%) fibrosis at 24 wk from Veh-treated Dsg2mut/mut (n = 4) and Dsg2mut/mut × Ccr2–/– mice (n = 4), and Bay11-treated Dsg2mut/mut (n = 5) and Dsg2mut/mut × Ccr2–/– mice (n = 5) at 24 wk. Data presented as mean ± SEM; *P < 0.05 any cohort versus Dsg2mut/mut (Veh); †P < 0.05 Bay11-treated mice versus Veh-treated mice within genotype; using 1-way ANOVA with Tukey’s posthoc analysis.
Figure 8 Contractile dysfunction is rescued in Dsg2mut/mut × Ccr2–/– mice via NFκB-inhibition. (A and B) Percent left ventricular ejection fraction (%LVEF) at 16 (16 wk) and 24 weeks (24 wk) of age in Dsg2mut/mut and Dsg2mut/mut × Ccr2–/– mice treated for 8 weeks with either vehicle (Veh) or the NFκB inhibitor, Bay11-7082 (Bay11; 5 mg/kg/day via continuous infusion at 0.11 μL/h for 8 weeks). Note, preserved cardiac function in Veh-treated Dsg2mut/mut × Ccr2–/– mice, whereas Bay11-treated Dsg2mut/mut × Ccr2–/– mice showed notable improvement in function following 8 weeks of Bay11 treatment. (C) Percent PVCs (%PVCs) at 24 wk. (D and E) Left ventricular internal diameter in diastole (LV diameter;d) and systole (LV diameter;s) at 16 wk and 24 wk in Dsg2mut/mut and Dsg2mut/mut × Ccr2–/– mice treated with either Veh or Bay11. (F) Representative trichrome-stained hearts (Scale bar: 1 mm) and (G) percent (%) fibrosis at 24 wk from Veh-treated Dsg2mut/mut (n = 4) and Dsg2mut/mut × Ccr2–/– mice (n = 4), and Bay11-treated Dsg2mut/mut (n = 5) and Dsg2mut/mut × Ccr2–/– mice (n = 5) at 24 wk. Data presented as mean ± SEM; *P < 0.05 any cohort versus Dsg2mut/mut (Veh); †P < 0.05 Bay11-treated mice versus Veh-treated mice within genotype; using 1-way ANOVA with Tukey’s posthoc analysis.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

21 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 40

Metadata

Authors
Chelko, S. P., Penna, V. R., Engel, M., Shiel, E. A., Centner, A. M., Farra, W., Cannon, E. N., Landim-Vieira, M., Schaible, N., Lavine, K., & Saffitz, J. E.
Affiliations
  • Florida State University (US)
  • Washington University in St. Louis (US)
  • Beth Israel Deaconess Medical Center (US)
Corresponding author
Chelko, Stephen P.
Venue
Journal of Clinical Investigation
Published
2024-04-02
Volume
134
Issue
10
ISSN
  • 0021-9738 (ISSN-L)
  • 1558-8238
OpenAlex
W4393549560
Cited by
32
References
43
Citations by year
2026: 13 · 2025: 13 · 2024: 6
FWCI
9.63
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Digital Commons@Becker (Washington University School of Medicine) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Institutes of Health (R01-HL148348, P30AR073752, R35 HL161185, 5T32AI007163-44)
  • American Heart Association (19CDA34760185)
  • Fondation Leducq (#20CVD02)
  • Burroughs Wellcome Fund (1014782)
  • Children’s Discovery Institute (CH-II-2015-462,CH-II-2017-628)
  • St. Louis Children’s Hospital (PM-LI-2019-829)
  • Foundation of Barnes-Jewish Hospital (8038-88)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Keywords
arrhythmogenic cardiomyopathy, NF-κB signaling, CCR2+ macrophages, myocardial injury, cardiomyocytes, macrophage recruitment, cardiac arrhythmias, contractile dysfunction, cardiac fibroblasts, inflammation, single-cell RNA sequencing, CITE-seq
MeSH terms
Animals, Disease Models, Animal, Humans, Macrophages, Myocardium, Signal Transduction, NF-kappa B, Arrhythmogenic Right Ventricular Dysplasia, Myocytes, Cardiac, Desmoglein 2, Mice, Receptors, CCR2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.